Press Releases

 
Select:
Aug 16, 2021
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2022 Ended June 30, 2021 and Provides Conference Call Information

Aug 10, 2021
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2022 Financial Results on August 17, 2021

Jun 14, 2021
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2021 and Provides Conference Call Information

Jun 08, 2021
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-End Financial Results on June 15, 2021

May 04, 2021
Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules

Apr 29, 2021
Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer

Feb 16, 2021
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2021 Ended December 31, 2020 and Provides Conference Call Information

Feb 10, 2021
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter of Fiscal Year 2021 Results on February 17, 2021

Jan 05, 2021
Elite Pharmaceuticals, Inc. Appoints Dr. Jason M. LePree as Vice President of Scientific Affairs

Nov 24, 2020
Elite Pharmaceuticals, Inc. Issues Statement on Product Approval Listing

   1    2   3   4   5   6